A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia
Misam Zawit1*, Carmelo Gurnari1,2*, Simona Pagliuca1,3 , Hassan Awada1, Jaroslaw P. Maciejewski1 and Yogen Saunthararajah1
*These authors contributed equally